Cargando…
Natural autoantibodies to the gonadotropin-releasing hormone receptor in polycystic ovarian syndrome
CONTEXT: Polycystic ovarian syndrome (PCOS) is a complex disease with different subtypes and unclear etiology. Among the frequent comorbidities are autoimmune diseases, suggesting that autoantibodies (aAb) may be involved in PCOS pathogenesis. OBJECTIVE: As the gonadal axis often is dysregulated, we...
Autores principales: | Sattler, Lisa-Marie, Schniewind, Hanna A., Minich, Waldemar B., Haudum, Christoph W., Niklowitz, Petra, Münzker, Julia, Kovács, Gábor L., Reinehr, Thomas, Obermayer-Pietsch, Barbara, Schomburg, Lutz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018624/ https://www.ncbi.nlm.nih.gov/pubmed/33798258 http://dx.doi.org/10.1371/journal.pone.0249639 |
Ejemplares similares
-
Autoimmunity to the Follicle-Stimulating Hormone Receptor (FSHR) and Luteinizing Hormone Receptor (LHR) in Polycystic Ovarian Syndrome
por: Schniewind, Hanna A., et al.
Publicado: (2021) -
Impact of Short-Term Isoflavone Intervention in Polycystic Ovary Syndrome (PCOS) Patients on Microbiota Composition and Metagenomics
por: Haudum, Christoph, et al.
Publicado: (2020) -
THU267 A Novel In Vitro Assay Correlates Insulin Receptor Autoantibodies To Fasting Insulin In Type B Insulin Resistance
por: Abel, Brent, et al.
Publicado: (2023) -
The role of gonadotropin‐releasing hormone neurons in polycystic ovary syndrome
por: McCartney, Christopher R., et al.
Publicado: (2022) -
Antagonistic Autoantibodies to Insulin-Like Growth Factor-1 Receptor Associate with Poor Physical Strength
por: Schwiebert, Christian, et al.
Publicado: (2020)